AI-Powered Care Navigation Reduces Healthcare Spend and Improves Patient Access

 

The U.S. healthcare system is strained by rising costs, uneven quality, and fragmented care navigation. Employers are bearing the brunt, spending more without always securing better care for their teams. According to the RAND Corporation, one effective strategy is to “change their network and benefit designs to encourage patients to use lower‑priced, higher‑value providers (where provider quality and convenience are comparable).” This strategy enables companies to save thousands of dollars per patient annually while enhancing the quality of care. As generative AI transforms industries, the question is no longer whether to adopt it, but how to do so ethically and effectively in healthcare.

Can AI help people find the right doctor—not just any doctor—while saving employers money and simplifying decision-making?

This episode of I Don’t Care, hosted by Dr. Kevin Stevenson, features Dr. Daniel Stein, internal medicine physician and CEO of Embold Health. Together, they unpack how Embold’s AI-powered platform is redefining care navigation through clinical logic, natural language processing, and massive datasets, guiding patients to high-performing providers matched to their needs and preferences.

Key Highlights from the Conversation:

  • AI That Guides, Not Replaces: Embold uses generative AI to replicate a physician’s triage logic and connect patients with the most appropriate, clinically validated provider, without needing a medical degree to navigate the platform.

  • Cost Savings Through Quality: Employers using Embold’s navigation tools have seen care costs drop 3–5% annually by steering employees to top providers, without relying on pricing alone.

  • Guardrails and Transparency: Backed by Microsoft’s responsible AI standards, Embold’s platform is bias-tested and built on a foundation of over 230 million medical records, ensuring recommendations prioritize outcomes and trust.

Dr. Daniel Stein is a physician and healthcare executive with deep experience across clinical care, health policy, and corporate leadership. He is the founder and CEO of Embold Health, where he leads efforts to improve care quality through data-driven physician performance analytics. Previously, he served as Chief Medical Officer at Walmart Care Clinics and held policy roles with the U.S. Senate and CMS, bringing a unique blend of clinical insight and system-level strategy to healthcare reform.

Article written by MarketScale.

Recent Episodes

Corganics is redefining standards in clinical cannabinoid care with THC-free, medical-grade CBD products developed for use exclusively by healthcare professionals. Backed by Advanced Lipid Technology, FDA-registered manufacturing, and rigorous third-party testing, Corganics offers a level of trust and transparency rare in the CBD space. In a conversation with Reggie Gatewood, President of Corganics, Brooke Williams,…

Corganics’ Clinical CBD Drops—THC-free, medical-grade, and developed with Advanced Lipid Technology—are designed for healthcare professionals seeking a trusted, science-backed cannabinoid solution for their patients. Manufactured in an FDA-registered facility and third-party lab-tested, these drops are a cornerstone of Corganics’ clinical approach. At Beautiphi Aesthetic Boutique, founder Kelly Hermans, CRNA, has integrated the drops into patient…

As healthcare costs continue to rise and patient needs become increasingly complex, personalization has emerged as a critical strategy in improving access, outcomes, and experiences. Despite 75% of surveyed Americans wishing for a more personalized healthcare experience, most health plans still offer one-size-fits-all solutions. But the shift toward personalization is more than just a…